CPT PLA Code for the IMMray™ PanCan-d test approved
LUND, SWEDEN – Immunovia AB (Nasdaq Stockholm: IMMNOV) announced, that Immunovia, Inc., its American subsidiary, has recently received approval for a Current Procedural Terminology (CPT) Proprietary Laboratory Analyses (PLA) code from the American Medical Association (AMA) for the IMMray™ PanCan-d test. The code will be effective on October 1, 2022. Immunovia is currently in process with the Centers of Medicare & Medicaid Services (CMS) to establish payment for IMMray™ PanCan-d with this PLA code which will be included in the 2023 CMS Clinical Lab Fee Schedule. “We are very pleased